How have BIAF shares performed in 2024?

bioAffinity Technologies' stock was trading at $1.4705 at the beginning of the year. Since then, BIAF stock has increased by 87.7% and is now trading at $2.76. View the best growth stocks for 2024 here .

Are investors shorting bioAffinity Technologies?

bioAffinity Technologies saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 55,100 shares, a decline of 12.1% from the March 15th total of 62,700 shares. Based on an average trading volume of 187,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.3% of the shares of the stock are sold short. View bioAffinity Technologies' Short Interest .

When is bioAffinity Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our BIAF earnings forecast .

When did bioAffinity Technologies IPO?

bioAffinity Technologies (BIAF) raised $8 million in an initial public offering (IPO) on Thursday, September 1st 2022. The company issued 1,300,000 shares at $6.00-$6.25 per share. WallachBeth Capital acted as the underwriter for the IPO and Craft Capital Management was co-manager.

How do I buy shares of bioAffinity Technologies?

Shares of BIAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BIAF

bioAffinity Technologies (BIAF) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free BIAF Stock Alerts

$2.76

+0.40 (+16.95%)

(As of 04/15/2024 ET)

Compare

Today's Range: $2.32
▼
$2.89
50-Day Range: $1.42
▼
$3.00
52-Week Range: $0.95
▼
$3.62

Volume: 442,744 shs
Average Volume: 171,572 shs
Market Capitalization: $31.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get bioAffinity Technologies alerts:

Ad InvestorPlace

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

About bioAffinity Technologies Stock (NASDAQ:BIAF)

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

BIAF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BIAF Stock News Headlines

April 16, 2024 | americanbankingnews.com

Comparing bioAffinity Technologies (BIAF) and The Competition

April 14, 2024 | americanbankingnews.com

Head-To-Head Survey: bioAffinity Technologies (BIAF) and Its Rivals

April 16, 2024 | InvestorPlace (Ad)

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

April 13, 2024 | americanbankingnews.com

Analyzing bioAffinity Technologies (BIAF) and Its Rivals

April 12, 2024 | americanbankingnews.com

bioAffinity Technologies (BIAF) & The Competition Head to Head Contrast

April 11, 2024 | americanbankingnews.com

Financial Contrast: bioAffinity Technologies (BIAF) vs. Its Rivals

April 11, 2024 | americanbankingnews.com

bioAffinity Technologies (BIAF) vs. Its Competitors Head-To-Head Survey

April 10, 2024 | americanbankingnews.com

Analyzing bioAffinity Technologies (BIAF) & Its Peers

April 16, 2024 | InvestorPlace (Ad)

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

April 10, 2024 | americanbankingnews.com

bioAffinity Technologies (BIAF) & The Competition Critical Analysis

April 9, 2024 | finance.yahoo.com

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

April 9, 2024 | businesswire.com

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

April 9, 2024 | americanbankingnews.com

Reviewing bioAffinity Technologies (BIAF) and Its Peers

April 9, 2024 | americanbankingnews.com

Critical Review: bioAffinity Technologies (BIAF) versus The Competition

April 8, 2024 | americanbankingnews.com

Reviewing bioAffinity Technologies (BIAF) & Its Rivals

April 8, 2024 | americanbankingnews.com

Contrasting bioAffinity Technologies (BIAF) & The Competition

April 7, 2024 | americanbankingnews.com

bioAffinity Technologies (BIAF) & Its Competitors Financial Contrast

April 7, 2024 | americanbankingnews.com

bioAffinity Technologies (BIAF) and The Competition Critical Review

March 8, 2024 | finance.yahoo.com

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 8, 2024 | finance.yahoo.com

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 6, 2024 | msn.com

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views

March 6, 2024 | marketwatch.com

BioAffinity Technologies Shares Plummet After Stock Sale

March 6, 2024 | msn.com

Why BioAffinity Technologies (BIAF) Shares Are Down 50%

March 6, 2024 | msn.com

BioAffinity Technologies to raise $2.5M from stock offering and private placement

March 6, 2024 | finance.yahoo.com

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 6, 2024 | businesswire.com

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 1, 2024 | finance.yahoo.com

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

See More Headlines

Receive BIAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:BIAF
CUSIP: N/A
CIK: 1712762
Web: www.bioaffinitytech.com
Phone: 210-698-5334
Fax: N/A
Employees: 14
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.90)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,940,000.00
Net Margins: -313.34%
Pretax Margin: -312.64%
Return on Equity: -107.20%
Return on Assets: -84.10%

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 1.77
Quick Ratio: 1.76

Sales & Book Value

Annual Sales: $2.53 million
Price / Sales: 12.56
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.51 per share
Price / Book: 5.41

Miscellaneous

Outstanding Shares: 11,510,000
Free Float: 6,413,000
Market Cap: $31.77 million
Optionable: Not Optionable
Beta: 3.93

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Steven Girgenti (Age 78)
Founder & Executive Chairman of the Board
Comp: $113.75k
Ms. Maria Zannes J.D. (Age 68)
Founder, President, CEO & Director
Comp: $299.17k
Ms. Julie Anne Overton
Director of Communications
Mr. Dallas J. Coleman
National Director of Sales
Dr. William Bauta Ph.D.
Senior Vice President of Therapeutics

Key Competitors

View All Competitors

BIAF Stock Analysis - Frequently Asked Questions

How have BIAF shares performed in 2024?: bioAffinity Technologies' stock was trading at $1.4705 at the beginning of the year. Since then, BIAF stock has increased by 87.7% and is now trading at $2.76.
View the best growth stocks for 2024 here.
Are investors shorting bioAffinity Technologies?: bioAffinity Technologies saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 55,100 shares, a decline of 12.1% from the March 15th total of 62,700 shares. Based on an average trading volume of 187,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.3% of the shares of the stock are sold short.
View bioAffinity Technologies' Short Interest.
When is bioAffinity Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our BIAF earnings forecast.

When did bioAffinity Technologies IPO?: bioAffinity Technologies (BIAF) raised $8 million in an initial public offering (IPO) on Thursday, September 1st 2022. The company issued 1,300,000 shares at $6.00-$6.25 per share. WallachBeth Capital acted as the underwriter for the IPO and Craft Capital Management was co-manager.
How do I buy shares of bioAffinity Technologies?: Shares of BIAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIAF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

bioAffinity Technologies (BIAF) Stock Price, News & Analysis

About bioAffinity Technologies Stock (NASDAQ:BIAF)

BIAF Stock Price History

BIAF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BIAF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info